Inhibrx Biosciences Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 1.45 M | $114.76 M | 9.41% | 9.39% |
| VIKING GLOBAL INVESTORS LP | 02/17/2026 | 1.44 M | $113.58 M | -19.58% | 9.29% |
| MORGAN STANLEY | 02/13/2026 | 1.17 M | $92.25 M | 163.68% | 7.54% |
| SANOFI | 02/11/2026 | 1.16 M | $91.48 M | 0.00% | 7.48% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 870.51 K | $68.77 M | -0.14% | 5.62% |
| BLACKROCK, INC. | 02/12/2026 | 777.38 K | $61.41 M | 13.53% | 5.02% |
| VANGUARD GROUP INC | 01/29/2026 | 623.08 K | $49.22 M | 4.73% | 4.03% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 454.66 K | $35.92 M | 3.31% | 2.94% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 02/11/2026 | 421.58 K | $33.30 M | 100.00% | 2.72% |
| STATE STREET CORP | 02/13/2026 | 374.96 K | $29.62 M | 83.87% | 2.42% |
| CALIGAN PARTNERS LP | 02/17/2026 | 323.57 K | $25.56 M | 36.88% | 2.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 297.12 K | $23.47 M | 100.00% | 1.92% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 275.92 K | $21.80 M | -7.35% | 1.78% |
| PFM HEALTH SCIENCES, LP | 02/17/2026 | 265.52 K | $20.98 M | 10.80% | 1.72% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 02/13/2026 | 264.00 K | $20.86 M | 100.00% | 1.71% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 226.01 K | $17.86 M | 1.84% | 1.46% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 214.73 K | $16.96 M | 120.50% | 1.39% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 210.20 K | $16.61 M | 100.00% | 1.36% |
| CALIGAN PARTNERS LP | 02/17/2026 | 150.00 K | $11.85 M | 100.00% | 0.97% |
| DLD ASSET MANAGEMENT, LP | 02/13/2026 | 143.50 K | $11.34 M | 100.00% | 0.93% |
| WOODLINE PARTNERS LP | 02/17/2026 | 139.48 K | $11.02 M | -58.56% | 0.90% |
| CITADEL ADVISORS LLC | 02/17/2026 | 137.40 K | $10.85 M | 100.00% | 0.89% |
| NORGES BANK | 02/10/2026 | 133.30 K | $10.53 M | 100.00% | 0.86% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 125.10 K | $9.88 M | 507.28% | 0.81% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 122.10 K | $9.65 M | 956.88% | 0.79% |
| INVESCO LTD. | 02/19/2026 | 112.40 K | $8.88 M | 539.56% | 0.73% |
| 02/13/2026 | 110.81 K | $8.75 M | 100.00% | 0.72% | |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 100.62 K | $7.95 M | 287.50% | 0.65% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 92.01 K | $7.27 M | 16.74% | 0.59% |
| NORTHERN TRUST CORP | 02/17/2026 | 88.51 K | $6.99 M | -4.48% | 0.57% |
| SUMMITTX CAPITAL, L.P. | 02/17/2026 | 82.89 K | $6.55 M | 53.09% | 0.54% |
| UBS GROUP AG | 01/29/2026 | 73.70 K | $5.82 M | 681.87% | 0.48% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2026 | 71.49 K | $5.65 M | -55.85% | 0.46% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 69.12 K | $5.46 M | 287.61% | 0.45% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 66.50 K | $5.25 M | 100.00% | 0.43% |
| DLD ASSET MANAGEMENT, LP | 02/13/2026 | 61.10 K | $4.83 M | 100.00% | 0.39% |
| CITIGROUP INC | 02/13/2026 | 55.76 K | $4.40 M | 1,021.69% | 0.36% |
| JANE STREET GROUP, LLC | 02/12/2026 | 52.90 K | $4.18 M | 100.00% | 0.34% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 52.60 K | $4.16 M | 526.19% | 0.34% |
| FMR LLC | 02/17/2026 | 46.27 K | $3.66 M | 17.65% | 0.30% |
| CITADEL ADVISORS LLC | 02/17/2026 | 43.80 K | $3.46 M | 100.00% | 0.28% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 42.60 K | $3.37 M | 100.00% | 0.28% |
| LAIRD NORTON TRUST COMPANY, LLC | 02/17/2026 | 40.38 K | $3.19 M | 100.00% | 0.26% |
| JANE STREET GROUP, LLC | 02/12/2026 | 37.00 K | $2.92 M | 100.00% | 0.24% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/17/2026 | 35.18 K | $2.78 M | 0.00% | 0.23% |
| JANE STREET GROUP, LLC | 02/12/2026 | 33.02 K | $2.61 M | -47.54% | 0.21% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 31.60 K | $2.50 M | 100.00% | 0.20% |
| MARSHALL WACE, LLP | 02/13/2026 | 29.31 K | $2.32 M | 7.59% | 0.19% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 29.31 K | $2.32 M | 70.75% | 0.19% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 28.39 K | $2.24 M | -4.59% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inhibrx Biosciences Inc. institutional Ownership - FAQ's
During the previous two years, 169 institutional investors and hedge funds held shares of Inhibrx Biosciences Inc.. The most heavily invested institutionals were:
Sanofi: 1.16 M
HighTower Advisors, LLC: 870,200
VANGUARD FIDUCIARY TRUST CO: 64,322
CITIGROUP INC: 62,516
UBS Group AG: 48,137
Jefferies Financial Group Inc.: 38,973
82.55% of Inhibrx Biosciences Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 13.60 M shares in the last 24 months. This purchase volume represents approximately $977.44 M in transactions.